{"id":"W2948320538","doi":"10.1080/2162402x.2019.1615817","title":"Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Sorafenib; Medicine; Oncolytic virus; Clinical endpoint; Hepatocellular carcinoma; Immunotherapy; Internal medicine; Randomized controlled trial; Oncology; Clinical trial; Gastroenterology; Surgery; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006648743,0.0005368624,0.001024036,0.0002923206,0.00007250252,0.00003682787,0.0005242888,0.0004292511,0.0006791634],"category_scores_gemma":[0.00009027279,0.0004604738,0.0003293584,0.0002822265,0.0002501298,0.00001971688,0.0001150692,0.0004061488,0.0001443396],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000190474,"about_ca_system_score_gemma":0.0005347718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005445917,"about_ca_topic_score_gemma":0.0001490804,"domain_scores_codex":[0.9962175,0.0008699963,0.0007398456,0.0009447573,0.0003721512,0.0008557569],"domain_scores_gemma":[0.9980334,0.0001196703,0.0002925851,0.001199799,0.0002437547,0.0001107905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7688606,0.001355849,0.01707071,0.00001921797,0.000266571,0.0000275893,0.00009258581,0.00006638632,0.209158,0.000002115022,0.00001256319,0.003067781],"study_design_scores_gemma":[0.8600651,0.02756993,0.003860982,0.00003780066,0.00004833762,0.000002519871,0.00004331208,0.0005964345,0.1052621,0.000005954682,0.001942982,0.0005645172],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933615,0.001186035,0.0002234187,0.0001407422,0.0002902785,0.004658525,0.00004198945,0.00002986281,0.00006762805],"genre_scores_gemma":[0.9972426,0.00007329039,0.0005934536,0.0004153035,0.00007531411,0.0008358919,0.0003970665,0.0001204585,0.0002466749],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1038959,"threshold_uncertainty_score":0.9997847,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005686685340311424,"score_gpt":0.2535832565696906,"score_spread":0.2478965712293792,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}